Overview

  • Product nameAnti-KLLN antibody
    See all KLLN primary antibodies
  • Description
    Rabbit polyclonal to KLLN
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to a region within C terminal amino acids 143-171 of Human KLLN (NP_001119521.1).

  • Positive control
    • MDA-MB435 cell line lysates.

Properties

Applications

Our Abpromise guarantee covers the use of ab110756 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 20 kDa.

Target

  • FunctionDNA-binding protein involved in S phase checkpoint control-coupled apoptosis by mediating p53/TP53-induced apoptosis. Has the ability to inhibit DNA synthesis and S phase arrest coupled to apoptosis. Has affinity to both double- and single-stranded DNA.
  • Cellular localizationNucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • CWS4 antibody
    • KILIN_HUMAN antibody
    • Killin antibody
    • Killin, p53-regulated DNA replication inhibitor antibody
    • KLLN antibody
    see all

Anti-KLLN antibody images

  • Anti-KLLN antibody (ab110756) at 1/100 dilution + MDA-MB435 cell line lysates at 35 µg

    Predicted band size : 20 kDa

References for Anti-KLLN antibody (ab110756)

This product has been referenced in:
  • Nizialek EA  et al. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest. Hum Mol Genet 22:2451-61 (2013). Human . Read more (PubMed: 23446638) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab110756.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"